Modified Single Repair Technique for Complete Atrioventricular Septal Defect: A Propensity Score Matching Analysis.
Atrioventricular septal defect
Congenital heart diseases
Left atrioventricular valve regurgitation
Journal
Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
11
09
2019
accepted:
17
01
2020
pubmed:
25
1
2020
medline:
1
9
2020
entrez:
25
1
2020
Statut:
ppublish
Résumé
There were controversies about the priority of modified single patch (MSP) technique compared with two-patch (TP) technique for patients with complete atrioventricular septal defect (CAVSD). From 2002 to 2013, patients who diagnosed as balanced CAVSD in our institution were retrospectively included. Patients with unbalanced ventricles or associated anomalies were excluded. The primary endpoint was all-cause mortality and the secondary endpoint consist of left atrioventricular dysfunction or left atrioventricular outflow tract obstruction (LVOTO). A total of 74 patients underwent MSP repair and 102 patients underwent TP repair. After 1:1 propensity matching, there were 46 Rastelli type A CAVSD patients in each group. Patients in MSP group had shorter cardiopulmonary bypass time [median (interquartile range) 73.5 (65.5-95.0) versus 105.0 (88.8-130.0) min, P < 0.001] and aortic cross-clamp time [105.5 (90.0-128.0) versus 143.0 (122.0-184.0) min, P < 0.001]. In total, the primary endpoint occurred in 12 patients, including 2/46 (4.3%) in MSP group and 10/46 (21.7%) in TP group. That 1-year, 3-year, 5-year survival rate can be calculated as 95.6%, 95.6%, 95.6% in MSP group and 92.6%, 80.4%, 78.2% in TP group, P = 0.015. No significant statistical difference found for the secondary endpoints that 7/46 (15.2%) patients occurred moderate or severe LAVVR in MSP group versus 11/46 (23.9%) patients in TP group, P = 0.293. No LVOTO occurred in both groups. Besides the simplicity of technique, MSP technique may be safer.
Identifiants
pubmed: 31974717
doi: 10.1007/s00246-020-02292-4
pii: 10.1007/s00246-020-02292-4
doi:
Types de publication
Comparative Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
615-623Subventions
Organisme : National Key R&D Program of China
ID : 2017YFC1308100
Références
Ann Thorac Surg. 2010 Sep;90(3):830-7
pubmed: 20732503
Semin Thorac Cardiovasc Surg. 2020 Spring;32(1):108-116
pubmed: 31306766
J Card Surg. 2015 Jul;30(7):595-600
pubmed: 25940208
Multimed Man Cardiothorac Surg. 2015 Oct 06;2015:
pubmed: 26443542
Int J Cardiol. 2016 Jan 1;202:784-95
pubmed: 26476030
Ann Thorac Surg. 2008 Aug;86(2):596-602
pubmed: 18640339
Interact Cardiovasc Thorac Surg. 2009 Apr;8(4):435-7; discussion 437-8
pubmed: 19181697
J Card Surg. 2013 Nov;28(6):756-63
pubmed: 24224745
J Am Soc Echocardiogr. 2017 Apr;30(4):303-371
pubmed: 28314623
Eur J Cardiothorac Surg. 2020 Jan 1;57(1):85-91
pubmed: 31006033
J Card Surg. 2012 Nov;27(6):745-53
pubmed: 23173863
Transl Pediatr. 2018 Apr;7(2):91-103
pubmed: 29770291
Ann Thorac Surg. 2014 Feb;97(2):666-71
pubmed: 24266947
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2007;:3-10
pubmed: 17433985
Ann Thorac Surg. 2012 Aug;94(2):599-605; discussion 605
pubmed: 22626757
J Card Surg. 2014 Mar;29(2):251-5
pubmed: 24495040
Interact Cardiovasc Thorac Surg. 2019 Mar 1;28(3):427-431
pubmed: 30239715
Eur J Cardiothorac Surg. 2014 Apr;45(4):610-7
pubmed: 24057432
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2007;:28-31
pubmed: 17433988
Interact Cardiovasc Thorac Surg. 2009 Jul;9(1):83-7
pubmed: 19372100
J Thorac Cardiovasc Surg. 2015 Aug;150(2):369-74
pubmed: 26048271
J Thorac Cardiovasc Surg. 1999 Oct;118(4):642-6
pubmed: 10504628
Pediatr Cardiol. 2014 Mar;35(3):393-8
pubmed: 24022512
Lancet Child Adolesc Health. 2018 Jun;2(6):430-439
pubmed: 30169284
Ann Thorac Surg. 2008 Jul;86(1):147-51; discussion 151-2
pubmed: 18573414